US 9636416
Immunoglobulin chimeric monomer-dimer hybrids
granted A61KA61K38/00A61K47/60
Quick answer
US patent 9636416 (Immunoglobulin chimeric monomer-dimer hybrids) held by BIOVERATIV THERAPEUTICS INC. expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K38/00, A61K47/60, A61K47/642, A61K47/68